Xarelto Lawsuit Attorneys in Saint Petersburg
Our Law Firm, Reeder and Nussbaum, P.A., IS CURRENTLY INVESTIGATING AND EVALUATING bleeding injuries associated with the use of Xarelto, an anti-clotting medication approved to prevent deep vein thrombosis (DVT), i.e. blood clotting; treat DVT and pulmonary embolism (PE); and prevent the formation of blood clots in patients.
XARELTO IS MORE DANGEROUS THAN TRADITIONAL BLOOD THINNERS: While bleeding is a common complication associated with anticoagulants, it is being alleged and appears that Xarelto is more dangerous than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, patients may be at risk for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging. A typically non-fatal wound can claim a person’s life. This is why it has been linked to so many deaths and serious complications.
BAYER and JOHNSON & JOHNSON’S HANSSEN HARMACEUTICALS, INC. are facing Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Plaintiffs in the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
Published reports indicate that through the end of 2014, worldwide sales of Xarelto® have topped $7.3billion and that over 3.2million prescriptions have been written for Xarelto®. As sales of Xarelto® increased, so too did adverse event reports associated with its use. For example, through the 1st quarter of 2013, as prescriptions grew to almost 990,000, reports of serious adverse events associated with Xarelto® approached 750,000.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
- The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
- The makers of the drug continue to market Xarelto as a safe anticoagulant option.
- Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
- Users of Xarelto were not adequately warned of the health risks
- Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
- If you or a loved one suffered a serious bleeding event after taking Xarelto, you may have legal recourse.
At Reeder & Nussbaum, Every Case and Client Is Unique and Important
At some firms, lawyers have a set way of doing things. The way they handle your case may be the same way they handled the last ten personal injury cases. At Reeder & Nussbaum, (St. Petersburg) we know that no two cases are the same. During your initial consultation, we will talk with you about your situation and give you an opportunity to tell us what you need from us.
If you call us with a question about your case, you will speak with an attorney — not a case manager or a paralegal. Even after regular business hours, we are still available to clients 24 hours a day, 7 days a week. We return all phone calls within 24 hours. We never leave our clients in the dark about the direction of their cases or about what we are doing to successfully resolve their claims.